139 related articles for article (PubMed ID: 26897666)
41. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.
Navarro WH; Loberiza FR; Bajorunaite R; van Besien K; Vose JM; Lazarus HM; Rizzo JD
Biol Blood Marrow Transplant; 2006 May; 12(5):541-51. PubMed ID: 16635789
[TBL] [Abstract][Full Text] [Related]
42. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.
Rathe M; Carlsen NL; Oxhøj H
Pediatr Blood Cancer; 2007 Jun; 48(7):663-7. PubMed ID: 17405151
[TBL] [Abstract][Full Text] [Related]
43. Improvement over the years of long-term survival in high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
Calderón-Cabrera C; Márquez-Malaver FJ; de la Cruz-Vicente F; Falantes F; Carrillo E; Parody R; Montero I; González Campos J; Martino ML; Carmona M; Pérez-Simón JA; Espigado I
Transplant Proc; 2013; 45(10):3665-7. PubMed ID: 24314990
[TBL] [Abstract][Full Text] [Related]
44. Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study.
Fox CS; Larson MG; Vasan RS; Guo CY; Parise H; Levy D; Leip EP; O'donnell CJ; D'Agostino RB; Benjamin EJ
J Am Soc Nephrol; 2006 Feb; 17(2):521-7. PubMed ID: 16382018
[TBL] [Abstract][Full Text] [Related]
45. Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.
Villa D; George A; Seymour JF; Toze CL; Crump M; Lee C; Buckstein R; Stewart DA; MacDonald D; Foley R; Xenocostas A; Sabloff M; Chua N; Couture F; Larouche JF; Cohen S; Savage KJ; Connors JM; Panzarella T; Carney DA; Dickinson M; Kuruvilla J
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1813-8. PubMed ID: 25042735
[TBL] [Abstract][Full Text] [Related]
46. [The role of dobutamine stress echocardiography in early diagnosis of cardiac toxicity in long-term survivors of asymptomatic children treated with anthracycline].
Yildirim A; Tunaoğlu FS; Pinarli FG; Ilhan M; Oğuz A; Karadeniz C; Olguntürk R; Oğuz D; Kula S
Anadolu Kardiyol Derg; 2010 Apr; 10(2):154-62. PubMed ID: 20382616
[TBL] [Abstract][Full Text] [Related]
47. Guideline Adherence for Echocardiographic Follow-Up in Outpatients with at Least Moderate Valvular Disease.
Chan RH; Shaw JL; Hauser TH; Markson LJ; Manning WJ
J Am Soc Echocardiogr; 2015 Jul; 28(7):795-801. PubMed ID: 25843026
[TBL] [Abstract][Full Text] [Related]
48. Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma.
Simensen VC; Smeland KB; Kiserud CE; Dahl AA; Bersvendsen HS; Fluge Ø; Fagerli UM; Fosså A
Acta Oncol; 2019 Sep; 58(9):1315-1322. PubMed ID: 31286808
[No Abstract] [Full Text] [Related]
49. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
[TBL] [Abstract][Full Text] [Related]
50. Heart valve disease associated with treatment with ergot-derived dopamine agonists: a clinical and echocardiographic study of patients with Parkinson's disease.
Rasmussen VG; Poulsen SH; Dupont E; Østergaard K; Safikhany G; Egeblad H
J Intern Med; 2008 Jan; 263(1):90-8. PubMed ID: 18036161
[TBL] [Abstract][Full Text] [Related]
51. Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.
van Nimwegen FA; Ntentas G; Darby SC; Schaapveld M; Hauptmann M; Lugtenburg PJ; Janus CPM; Daniels L; van Leeuwen FE; Cutter DJ; Aleman BMP
Blood; 2017 Apr; 129(16):2257-2265. PubMed ID: 28143884
[TBL] [Abstract][Full Text] [Related]
52. A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma.
Shimoni A; Avivi I; Rowe JM; Yeshurun M; Levi I; Or R; Patachenko P; Avigdor A; Zwas T; Nagler A
Cancer; 2012 Oct; 118(19):4706-14. PubMed ID: 22252613
[TBL] [Abstract][Full Text] [Related]
53. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
[TBL] [Abstract][Full Text] [Related]
54. Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress.
Bersvendsen HS; Haugnes HS; Dahl AA; Fagerli UM; Fluge Ø; Holte H; Wilsgaard T; Smeland KB; Kiserud CE
Bone Marrow Transplant; 2021 Apr; 56(4):968-970. PubMed ID: 33139869
[TBL] [Abstract][Full Text] [Related]
55. Low dose cabergoline for hyperprolactinaemia is not associated with clinically significant valvular heart disease.
Wakil A; Rigby AS; Clark AL; Kallvikbacka-Bennett A; Atkin SL
Eur J Endocrinol; 2008 Oct; 159(4):R11-4. PubMed ID: 18625690
[TBL] [Abstract][Full Text] [Related]
56. Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment.
Elenkova A; Shabani R; Kalinov K; Zacharieva S
Eur J Endocrinol; 2012 Jul; 167(1):17-25. PubMed ID: 22511808
[TBL] [Abstract][Full Text] [Related]
57. Drug-induced valvular heart disease: an update.
Andrejak M; Tribouilloy C
Arch Cardiovasc Dis; 2013 May; 106(5):333-9. PubMed ID: 23769407
[TBL] [Abstract][Full Text] [Related]
58. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
[TBL] [Abstract][Full Text] [Related]
59. Treatment exposures stratify need for echocardiographic screening in asymptomatic long-term survivors of hematopoietic stem cell transplantation.
Rotz SJ; Powell A; Myers KC; Taylor MD; Jefferies JL; Lane A; El-Bietar JA; Davies SM; Dandoy CE; Ryan TD
Cardiol Young; 2019 Mar; 29(3):338-343. PubMed ID: 30744727
[TBL] [Abstract][Full Text] [Related]
60. Multiple and Mixed Valvular Heart Diseases.
Unger P; Pibarot P; Tribouilloy C; Lancellotti P; Maisano F; Iung B; Piérard L;
Circ Cardiovasc Imaging; 2018 Aug; 11(8):e007862. PubMed ID: 30354497
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
